Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04458961Not ApplicableCompleted

MIKROBE Management of Infected Knee Replacements-Obtaining Best Evidence

Role: collaborator

NCT04792606Recruiting

Long-Term Outcomes of Hip Interventions for Children With Cerebral Palsy

Role: collaborator

NCT00974883Completed

Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)

Role: collaborator

NCT00618085Phase 2Completed

Motor Imagery Practice in Neurological Rehabilitation

Role: lead

All 4 trials loaded